PharmaResources Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 1,155

Employees

  • Stock Symbol
  • 301230

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $3.54
  • (As of Friday Closing)

PharmaResources General Information

Description

Pharma Resources (Shanghai) Co Ltd is engaged in the drug discovery, research, and development of pharmaceutical processes, and commercial production of API intermediates.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Building 7, Number 509, Renqing Road
  • Pudong
  • Shanghai, 201201
  • China
+86 021
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
SHE
Corporate Office
  • Building 7, Number 509, Renqing Road
  • Pudong
  • Shanghai, 201201
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaResources Stock Performance

As of 20-Nov-2026, PharmaResources’s stock price is $3.54. Its current market cap is $641M with 181M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.54 $3.80 $3.16 - $7.49 $641M 181M 18.9M $0.02

PharmaResources Financials Summary

As of 30-Sep-2026, PharmaResources has a trailing 12-month revenue of $105M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,018,102 577,697 464,129 490,139
Revenue 105,147 95,720 75,880 69,219
EBITDA 4,504 12,040 8,188 10,209
Net Income 4,149 4,769 2,381 5,317
Total Assets 191,933 187,817 180,330 209,797
Total Debt 21,512 23,627 24,891 29,111
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PharmaResources Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmaResources‘s full profile, request access.

Request a free trial

PharmaResources Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore PharmaResources‘s full profile, request access.

Request a free trial

PharmaResources Patents

PharmaResources Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12338255-B2 Bicyclic substituted sulfonylurea compounds as inhibitors of interleukin-1 activity Active 21-Feb-2022
US-20230279026-A1 Novel bicyclic substituted sulfonylurea compounds as inhibitors of interleukin-1 activity Active 21-Feb-2022
US-20250230140-A1 Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists Pending 30-Apr-2021
US-11040036-B2 Pyruvate kinase activators for use in treating blood disorders Active 18-May-2018
US-11364240-B2 Pyruvate kinase activators for use in treating blood disorders Active 18-May-2018 C07D513/14
To view PharmaResources’s complete patent history, request access »

PharmaResources Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaResources Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PharmaResources‘s full profile, request access.

Request a free trial

PharmaResources Investments (1)

PharmaResources’s most recent deal was a Early Stage VC with BioMeta (Shanghai). The deal was made on 18-Sep-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BioMeta (Shanghai) 18-Sep-2024 Early Stage VC Drug Discovery
To view PharmaResources’s complete investments history, request access »

PharmaResources ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view PharmaResources’s complete esg history, request access »

PharmaResources FAQs

  • When was PharmaResources founded?

    PharmaResources was founded in 2007.

  • Where is PharmaResources headquartered?

    PharmaResources is headquartered in Shanghai, China.

  • What is the size of PharmaResources?

    PharmaResources has 1,155 total employees.

  • What industry is PharmaResources in?

    PharmaResources’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is PharmaResources a private or public company?

    PharmaResources is a Public company.

  • What is PharmaResources’s stock symbol?

    The ticker symbol for PharmaResources is 301230.

  • What is the current stock price of PharmaResources?

    As of 20-Nov-2026 the stock price of PharmaResources is $3.54.

  • What is the current market cap of PharmaResources?

    The current market capitalization of PharmaResources is $641M.

  • What is PharmaResources’s current revenue?

    The trailing twelve month revenue for PharmaResources is $105M.

  • What is PharmaResources’s annual earnings per share (EPS)?

    PharmaResources’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process